GLSI Valuation

Greenwich Lifesciences Inc

Add to Watchlist

Advanced Chart

12.170

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

GLSI Relative Valuation

GLSI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GLSI is overvalued; if below, it's undervalued.

Historical Valuation

Greenwich Lifesciences Inc (GLSI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -30.22. The fair price of Greenwich Lifesciences Inc (GLSI) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：12.17

Fair

-12.95

Trailing

Forward

0.00

EV/EBITDA

Greenwich Lifesciences Inc. (GLSI) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-12.62

EV/EBIT

Greenwich Lifesciences Inc. (GLSI) has a current EV/EBIT of -12.62. The 5-year average EV/EBIT is -26.68. The thresholds are as follows: Strongly Undervalued below -93.50, Undervalued between -93.50 and -60.09, Fairly Valued between 6.72 and -60.09, Overvalued between 6.72 and 40.13, and Strongly Overvalued above 40.13. The current Forward EV/EBIT of -12.62 falls within the Historic Trend Line -Fairly Valued range.

0.00

Greenwich Lifesciences Inc. (GLSI) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Greenwich Lifesciences Inc. (GLSI) has a current P/OCF of 0.00. The 5-year average P/OCF is -19.35. The thresholds are as follows: Strongly Undervalued below -111.08, Undervalued between -111.08 and -65.21, Fairly Valued between 26.51 and -65.21, Overvalued between 26.51 and 72.37, and Strongly Overvalued above 72.37. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

1.54

P/FCF

Greenwich Lifesciences Inc. (GLSI) has a current P/FCF of 1.54. The 5-year average P/FCF is -5.07. The thresholds are as follows: Strongly Undervalued below -25.81, Undervalued between -25.81 and -15.44, Fairly Valued between 5.30 and -15.44, Overvalued between 5.30 and 15.68, and Strongly Overvalued above 15.68. The current Forward P/FCF of 1.54 falls within the Historic Trend Line -Fairly Valued range.

Greenwich Lifesciences Inc (GLSI) has a current Price-to-Book (P/B) ratio of 113.91. Compared to its 3-year average P/B ratio of 29.77 , the current P/B ratio is approximately 282.65% higher. Relative to its 5-year average P/B ratio of 24.43, the current P/B ratio is about 366.16% higher. Greenwich Lifesciences Inc (GLSI) has a Forward Free Cash Flow (FCF) yield of approximately -5.16%. Compared to its 3-year average FCF yield of -4.41%, the current FCF yield is approximately 17.10% lower. Relative to its 5-year average FCF yield of -3.23% , the current FCF yield is about 59.90% lower.

113.91

P/B

Median3y

29.77

Median5y

24.43

-5.16

FCF Yield

Median3y

-4.41

Median5y

-3.23

Competitors Valuation Multiple

The average P/S ratio for GLSI's competitors is 5.58, providing a benchmark for relative valuation. Greenwich Lifesciences Inc Corp (GLSI) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

GLSI.O

Greenwich Lifesciences Inc

Elicio Therapeutics Inc

Black Diamond Therapeutics Inc

Loss

157.14M

Performance Decomposition

Market capitalization of GLSI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of GLSI in the past 1 year is driven by Unknown.